User talk:Pikapika0713

Welcome
Welcome to Wikipedia! We have compiled some guidance for new healthcare editors:
 * 1) Please keep the mission of Wikipedia in mind. We provide the public with accepted knowledge, working in a community.
 * 2) We do that by finding high quality secondary sources and summarizing what they say, giving WP:WEIGHT as they do.  Please do not try to build content by synthesizing content based on primary sources.
 * 3) Please use high-quality, recent, secondary sources for medical content (see WP:MEDRS; for the difference between primary and secondary sources, see the WP:MEDDEF section.) High-quality sources include review articles (which are not the same as peer-reviewed), position statements from nationally and internationally recognized bodies (like CDC, WHO, FDA), and major medical textbooks. Lower-quality sources are typically removed. Please beware of predatory publishers – check the publishers of articles (especially open source articles) at Beall's list.
 * 4) The ordering of sections typically follows the instructions at WP:MEDMOS. The section above the table of contents is called the WP:LEAD. It summarizes the body. Do not add anything to the lead that is not in the body. Style is covered in MEDMOS as well; we avoid the word "patient" for example.
 * 5) We don't use terms like "currently", "recently," "now", or "today". See WP:RELTIME.
 * 6) More generally see WP:MEDHOW, which gives great tips for editing about health -- for example, it provides a way to format citations quickly and easily
 * 7) Citation details are important:
 * 8) *Be sure to cite the PMID for journal articles and ISBN for books
 * 9) *Please include page numbers when referencing a book or long journal article, and please format citations consistently within an article.
 * 10) *Do not use URLs from your university library that have "proxy" in them: the rest of the world cannot see them.
 * 11) *Reference tags generally go after punctuation, not before; there is no preceding space.
 * 12) We use very few capital letters (see WP:MOSCAPS) and very little bolding. Only the first word of a heading is usually capitalized.
 * 13) Common terms are not usually wikilinked; nor are years, dates, or names of countries and major cities. Avoid overlinking!
 * 14) Never copy and paste from sources; we run detection software on new edits.
 * 15) Talk to us! Wikipedia works by collaboration at articles and user talkpages.

Once again, welcome, and thank you for joining us! Please share these guidelines with other new editors.

– the WikiProject Medicine team Doc James  (talk · contribs · email) 22:16, 31 January 2020 (UTC)

Acute bronchitis
How does this related

"Resistance to antibiotics may develop rapidly and last for 10 to 14 days. Thus, patients who are taking amoxicillin for acute bronchitis should be prescribed another type of antibiotic, (such as clindamycin or a cephalosporin) when an antibiotic is needed for an odontogenic infection. "

Why would people be taking amoxicillin for acute bronchitis, a viral infection? And viruses do not develop resistance... Doc James (talk · contribs · email) 22:18, 31 January 2020 (UTC)

Text
"== Oral Manifestations and Complications == Nasal symptoms, allergic rhinitis, and mouth breathing are common with extrinsic asthma. Patients with asthma who are mouth breathers may have altered naso-respira­tory function, which may be associated with increased upper anterior and total anterior facial height, higher palatal vault, greater overjet, and a higher prevalence of crossbite. The medications taken by patients who have asthma may contribute to oral disease. For example, β2-agonist inhalers reduce salivary flow by 20% to 35%, decrease plaque pH, and are associated with increased preva­lence of gingivitis and caries in patients with moderate to severe asthma. Gastroesophageal acid reflux is common in patients with asthma and is exacerbated by the use of β-agonists and theophylline. This reflux can contribute to erosion of enamel. Oral candidiasis (acute pseudomembranous type) occurs in approximately 5% of patients who use inhalation steroids for long periods at high dose or frequency. However, development of this condition is rare if a “spacer” or aerosol-holding chamber is attached to the metered-dose inhaler and the mouth is rinsed with water after each use. The condi­tion readily responds to local antifungal therapy (i.e., nystatin, clotrimazole, or fluconazole). Patients should receive instructions on the proper use of their inhaler and the need for oral rinsing. Headache is a frequent adverse effect of antileukotrienes and theophylline. The clinician should be aware of this adverse effect when diagnosing disease in patients with orofacial pain complaints." This needs work. Some of the refs are super old. Others are primary and others do not support the content in question. Doc James  (talk · contribs · email) 23:32, 31 January 2020 (UTC)

This has similar issues
Also why does management have a capital? Much of this is unsupported... Doc James (talk · contribs · email) 23:35, 31 January 2020 (UTC)

Dental Management
The underlying primary goal in dental management of patients with asthma is to prevent an acute asthma attack. The first step in achieving this goal is to iden­tify patients with asthma by history, followed by assess­ment to elucidate the surrounding details of the problem, along with prevention of precipitating factors.

Through a good history, the dentist should be able to determine the severity and stability of disease. Questions should be asked that ascertain the type of asthma (e.g., allergic versus nonallergic), the precipitating substances, the frequency and severity of attacks, the times of day when attacks occur, whether this is a current or past problem, how attacks usually are managed, and whether the patient has received emergency treatment for an acute attack. The clinician must be cognizant of the indications of severe disease: frequent exacerbations, exercise intolerance, FEV1 less than 60%, use of several medications, and a history of visits to an emergency facility for treatment of acute attack.

The stability of the disease can be assessed during the interview component of the history and by clinical exam­ination and the results of laboratory measures. Features such as shortness of breath, wheezing, increased respira­tory rate (more than 50% above normal), FEV1 that has fallen more than 10% or to below 80% of peak FEV1, an eosinophil count that is elevated to above 50/mm3, poor drug use compliance, and emergency department visits within the previous 3 months suggest inadequate treatment and poor stability. Also, the use of more than 1.5 canisters of a beta agonist inhaler per month (more than 200 inhalations per month) or doubling of monthly use indicates high risk for a severe asthma attack. For severe and unstable asthma, consultation with the patient’s physician is advised. Routine dental treatment should be postponed until better control is achieved.

Modifications during the preoperative and operative phases of dental management of a patient with asthma can minimize the likelihood of an attack. Patients who have nocturnal asthma should be scheduled for late-morning appointments, when attacks are less likely. Use of operatory odorants (e.g., methyl methacrylate) should be reduced before the patient is treated. Patients should be instructed to regularly use their medications, to bring their inhalers (bronchodilators) to each appointment, and to inform the dentist at the earliest sign or symptom of an asthma attack. Prophylactic inhalation of a patient’s bronchodilator at the beginning of the appointment is a valuable method of preventing an asthma attack. Alter­natively, patients may be advised to bring their spirom­eter and daily expiratory record to the office. The dentist may request that the patient exhale into the spirometer and record the expired volume. A significant drop in lung function (to below 80% of peak FEV1 or a greater than 10% drop from previously recorded values) indicates that prophylactic use of the inhaler or referral to a physi­cian is needed. The use of a pulse oximeter also is valu­able for determining the patient’s oxygen saturation level. In healthy patients, this value remains between 97% and 100%, whereas a drop to 91% or below indicates poor oxygen exchange and the need for intervention.

Because stress is implicated as a precipitating factor in asthma attacks and dental treatment may result in decreased lung function, all dental staff members should make every effort to identify patients who are anxious and provide a stress-free environment through establishment of rapport and openness. Preoperative and intraoperative sedation may be desirable. If sedation is required, nitrous oxide–oxygen inhalation is best. Nitrous oxide is not a respiratory depressant, nor is it an irritant to the tracheobronchial tree. Oral premedica­tion may be accomplished with small doses of a short-acting benzodiazepine. Reasonable alternatives with children are hydroxyzine (Vistaril), for its antihistamine and sedative properties, and ketamine, which causes bronchodilation. Barbiturates and narcotics, particularly meperidine, are histamine-releasing drugs that can provoke an attack. Outpatient general anesthesia gener­ally is contraindicated for patients with asthma.

Selection of local anesthetic may require adjustment. In 1987, the U.S. Food and Drug Administration (FDA) warned that drugs that contained sulfites were a cause of allergic-type reactions in susceptible individu­als. Sulfite preservatives are found in local anesthetic solutions that contain epinephrine or levonordefrin, although the amount of sulfite in a local anesthetic car­tridge is less than the amount commonly found in an average serving of certain foods. Although rare, at least one case of an acute asthma attack precipitated by expo­sure to sulfites has been reported. Thus, the use of local anesthetic without epinephrine or levonordefrin may be advisable for patients with moderate to severe disease. Because relevant data remain limited, the dentist should discuss with the patient any past responses to local anes­thetics and allergy to sulfites and should consult with the physician on this issue. As an alternative, local anes­thetics without a vasoconstrictor may be used in at-risk patients.

Patients with asthma who are medicated over the long term with systemic corticosteroids may require supple­mentation for major surgical procedures if their health is poor. However, long-term use of inhaled corticosteroids rarely causes adrenal suppression unless the daily dosage exceeds 1.5 mg of beclometha­sone dipropionate or its equivalent. Administration of aspirin-containing medication or other nonsteroidal anti-inflammatory drugs to patients with asthma is not advisable, because aspirin ingestion is associated with the precipitation of asthma attacks in a small percentage of patients. Likewise, barbiturates and narcotics are best not used, because they also may precipitate an asthma attack. Antihistamines have ben­eficial properties but should be used cautiously because of their drying effects. Patients who are taking theophyl­line preparations should not be given macrolide antibiot­ics (i.e., erythromycin and azithromycin) or ciprofloxacin hydrochloride, because these agents interact with the­ophylline to produce a potentially toxic blood level of theophylline. To prevent serious toxicity, the dentist should ask the patient who takes theophylline whether the dosage is being monitored on the basis of serum theophylline levels (recommended to be less than 10 μg/ mL). Approximately 3% of patients who take zileuton exhibit elevated alanine transaminase levels, reflecting liver dysfunction that may affect the metabolism of den­tally administered drugs.

Text
Nasal symptoms, allergic rhinitis, and mouth breathing are common with extrinsic asthma. Patients with asthma who are mouth breathers may have altered naso-respira­tory function, which may be associated with increased upper anterior and total anterior facial height, higher palatal vault, greater overjet, and a higher prevalence of crossbite.


 * Why a 1983 primary source? Did you read any of the above... Doc James  (talk · contribs · email) 02:19, 24 February 2020 (UTC)

The medications taken by patients who have asthma may contribute to oral disease. For example, β2-agonist inhalers reduce salivary flow by 20% to 35%, decrease plaque pH, and are associated with increased preva­lence of gingivitis and caries in patients with moderate to severe asthma.


 * This is another oldish primary source.

Gastroesophageal acid reflux is common in patients with asthma and is exacerbated by the use of β-agonists and theophylline. This reflux can contribute to erosion of enamel. Oral candidiasis (acute pseudomembranous type) occurs in approximately 5% of patients who use inhalation steroids for long periods at high dose or frequency.


 * Why a paper on tuberculosis in the asthma article? We already discuss thrush in the article. Doc James  (talk · contribs · email) 02:22, 24 February 2020 (UTC)

However, development of this condition is rare if a “spacer” or aerosol-holding chamber is attached to the metered-dose inhaler and the mouth is rinsed with water after each use. The condi­tion readily responds to local antifungal therapy (i.e, nystatin, clotrimazole, or fluconazole). Patients should receive instructions on the proper use of their inhaler and the need for oral rinsing. Headache is a frequent adverse effect of antileukotrienes and theophylline.


 * Did you read the recommendation above. Doc James  (talk · contribs · email) 02:19, 24 February 2020 (UTC)

Rinsing the mouth
Have added the bit on rinsing here

Thrush was already mentioned. Doc James (talk · contribs · email) 02:34, 24 February 2020 (UTC)

Text
A higher prevalence of caries is noted among patients with asthma, particularly children, that may be related to the disease and/or its treatment. Asthma may impact dental caries susceptibility either directly through biological changes, such as salivary composition, or indirectly as side effects of the medicines used to control the symptoms of asthma. For example, the prolonged use of beta 2 agonists has been associated with a decrease in salivary production. Beta 2 agonists work to relax constricted smooth muscles that comprise the airway. This tranquilizing effect occasionally impacts smooth muscles outside of the airway, such as the lower esophageal sphincter which prevents gastroesophageal acid reflux. However, when relaxed under the influence of beta 2 agonists, the smooth muscle allows erosive gastric acid to enter the mouth. Repeated exposure to such acidic conditions poses a significant threat to the dentition and may result in erosion of primary teeth in children. Both aerosol and powdered forms of asthma medications have a pH less than the critical level of pH 5.5 will lead to enamel dissolution.

Teeth
Cavities occur more often in people with asthma. This may be related to the effect of beta 2 agonists decreasing saliva. These medications may also increase the risk of dental erosions.


 * Adjusting to this. The other refs are either primary or do not mention asthma. Doc James  (talk · contribs · email) 21:19, 26 February 2020 (UTC)


 * Okay adjusted the text and put it here https://en.wikipedia.org/w/index.php?title=Asthma&diff=942790878&oldid=942787799&diffmode=source Doc James  (talk · contribs · email) 21:21, 26 February 2020 (UTC)